LLY

1,045.35

-1.18%↓

JNJ

205.34

-0.12%↓

ABBV

224.4

-0.21%↓

UNH

324.92

+0.43%↑

AZN

90.2

-0.31%↓

LLY

1,045.35

-1.18%↓

JNJ

205.34

-0.12%↓

ABBV

224.4

-0.21%↓

UNH

324.92

+0.43%↑

AZN

90.2

-0.31%↓

LLY

1,045.35

-1.18%↓

JNJ

205.34

-0.12%↓

ABBV

224.4

-0.21%↓

UNH

324.92

+0.43%↑

AZN

90.2

-0.31%↓

LLY

1,045.35

-1.18%↓

JNJ

205.34

-0.12%↓

ABBV

224.4

-0.21%↓

UNH

324.92

+0.43%↑

AZN

90.2

-0.31%↓

LLY

1,045.35

-1.18%↓

JNJ

205.34

-0.12%↓

ABBV

224.4

-0.21%↓

UNH

324.92

+0.43%↑

AZN

90.2

-0.31%↓

Search

Odonate Therapeutics Inc

Fermé

0

Résumé

Variation du prix de l'action

24h

Actuel

Min

Max

Chiffres clés

By Trading Economics

Odonate Therapeutics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

2 déc. 2025, 17:29 UTC

Principaux Mouvements du Marché
Acquisitions, Fusions, Rachats

Laurentian Bank Shares Hit Two-Year High on Plans for Break-Up, Takeover

2 déc. 2025, 16:21 UTC

Résultats

Scotiabank Aiming for Earnings Growth After Capital Markets Buoy Results in Latest Quarter -- Update

2 déc. 2025, 16:18 UTC

Résultats

Correction to Scotiabank Quarterly Earnings Buoyed Article

2 déc. 2025, 23:53 UTC

Market Talk

Nikkei May Rise After Gains on Wall Street -- Market Talk

2 déc. 2025, 22:48 UTC

Résultats

Marvell's Stock Soars On Data Center Forecast -- Barrons.com

2 déc. 2025, 22:12 UTC

Market Talk

Australian 3Q GDP To Show Modest Recovery In Play -- Market Talk

2 déc. 2025, 22:03 UTC

Market Talk

Minerals 260's Resource Upgrade Looks Impressive -- Market Talk

2 déc. 2025, 22:00 UTC

Market Talk

Global Equities Roundup: Market Talk

2 déc. 2025, 22:00 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

2 déc. 2025, 22:00 UTC

Market Talk

Fletcher Building Loses Bull Due to Tame Housing-Market Recovery -- Market Talk

2 déc. 2025, 21:56 UTC

Résultats

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2 déc. 2025, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

2 déc. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2 déc. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

2 déc. 2025, 21:44 UTC

Résultats

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2 déc. 2025, 21:38 UTC

Market Talk

Sky Network TV Has Path to Grow Dividend by 33% -- Market Talk

2 déc. 2025, 21:19 UTC

Résultats

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2 déc. 2025, 20:06 UTC

Market Talk

Oil Futures Fall Amid Russia-Ukraine Peace Talks -- Market Talk

2 déc. 2025, 19:55 UTC

Market Talk

Natural Gas Futures Fall Amid Uncertain Weather Forecasts -- Market Talk

2 déc. 2025, 19:53 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

2 déc. 2025, 19:53 UTC

Market Talk
Résultats

Scotiabank ROE Target Viewed as Possibly Conservative -- Market Talk

2 déc. 2025, 19:24 UTC

Market Talk

Analysts Project Uptick in U.S. Ethanol Stocks -- Market Talk

2 déc. 2025, 19:06 UTC

Market Talk

Precious Metals Step Back After Silver Sets Record -- Market Talk

2 déc. 2025, 18:27 UTC

Acquisitions, Fusions, Rachats

Kraken to Acquire Backed Finance AG

2 déc. 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

2 déc. 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

2 déc. 2025, 15:17 UTC

Market Talk

Natural Gas Extends Gains Amid Cold Weather -- Market Talk

2 déc. 2025, 14:47 UTC

Market Talk

BOE Likely to Cut Rates Further, Weakening Sterling -- Market Talk

2 déc. 2025, 14:38 UTC

Market Talk

Silver Steps Back From Record Levels -- Market Talk

2 déc. 2025, 14:31 UTC

Market Talk
Résultats

Scotiabank Strong Quarter Driven By Capital Markets Growth -- Market Talk

Comparaison

Variation de prix

Odonate Therapeutics Inc prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

EBITDA

Bénéfice d'exploitation

$

À Propos Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat